Will US FDA Change Its Conflict Of Interest Policies In Wake Of McKinsey’s Work With Purdue?

House Oversight Committee members grill McKinsey global managing partner about whether the firm told FDA about its simultaneous work for opioid maker Purdue. Agency says it does not anticipate future contracts with McKinsey until investigations are completed.